|Company||Round/Series||Amount (M)||Investors||What’s it for||What they do|
|Gympass||N/A||$300||SoftBank’s Vision Fund Latin America Fund, General Atlantic, Atomico, Valor Capital Group||The new funding will allow Gympass to further personalize the user experience of its product. The startup also told Bloomberg that it will be expanding its service into the Asian region.|
Gympass allows employers to provide employees with monthly passes that can be redeemed for gym access and various fitness classes. Through the app, members can search for locations that support a Gympass, lookup specific class schedules and check into their session via GPS.
|Tencent Trusted Doctor||N/A||$250||Country Garden Holdings, Tencent Holdings and Sequoia Capital||N/A|
Tencent Trusted Doctor said it connects 440,000 certified doctors with more than 10 million patients online, offering services from online consulting to e-commerce to physical checks.
|Collective Health||Series E||$205||SoftBank, PSP Investments, DFJ Growth, G Squared, Founders Fund, GV, Maverick Ventures, Mubadala Ventures, NEA and Sun Life||Collective Health is targeting new strategic partnerships within the US; bumping up its sales, engineering and customer experience teams; and developing new capabilities to its platform.|
Promising an alternative to hectic multi-vendor implementations, Collective Health’s suite of software offers a centralized hub for employers to manage members, conduct administrative tasks, optimize networks and point solutions, and gauge performance. Members, meanwhile, have access to an online and mobile portal that handles benefit navigation and, with the help of predictive analytics, matches members to the programs that would most benefit them.
|DocPlanner||Series E||$90.90||One Peak Partners, Goldman Sachs Private Capital Investing, Piton Capital and ENERN Investments||The company said that it would use the new funding to continue its push in core European and Latin American markets, purse R&D activities and expand its team.|
DocPlanner’s online doctor booking services offers doctors and clinics a SaaS tool to improve patient flow and help digitize their practices, and allows patients to book appointments through its online marketplace with healthcare professionals.
|Tonal||Series C||$90||The Growth Fund of L Catterton, Evolution Media, Shasta Ventures, Mayfield, Serena Ventures and Sapphire Ventures||The company plans to use the new funding to create new “personalized software experiences” for the device, hire new talent and expand its video content library.|
Tonal offers a special connected exercise machine with a AI-powered fitness software, all focused on the goal of strength training. Rather than traditional weights, the machine uses “digital weights” that use magnetic force to provide resistance.
|Ro||Series B||$85||N/A||The company did not disclose its plans for the new money.|
Ro made a name for itself in the digital health world with its online platform that specializes in men’s health, but has recently expanded to smoking cessation and women’s health.
|Omada Health||N/A||$73||Wellington Management Company, Cigna Ventures, Andreessen Horowitz, U.S. Venture Partners, Norwest Venture Partners, Kaiser Permanente Ventures, Sanofi Ventures, Civilization Ventures and Providence Ventures||The funding will help ongoing scaling efforts for its digital care program.|
Omada offers a slew of digital coaching programs addressing hypertension, Type 2 diabetes, mental health conditions and other health needs. The company also implements connected technology to track participants and hold them accountable — for instance, a wireless scale, a pedometer, and a mobile app to track food and activity for its diabetes program.
|Jawbone Health||N/A||$65.40||N/A||The company did not disclose specific directions for its new funding.|
Jawbone Health sees itself as “a personalized subscription service that utilizes continuous health information combined with human and machine intelligence to take care of its members on a daily basis.”
|Cityblock||Series B||$65||Redpoint Ventures, 8VC, Echo Health Ventures, StartUp Health, Sidewalk Labs, Thrive Capital, Maverick Ventures, Town Hall Ventures and EmbelmHealth||The company will use the new money to expand the team and grow its reach into both existing and new markets. It also plans to invest in technical product capabilities and add new services.|
Cityblock, a spinout of Alphabet subsidiary Sidewalk Labs, looks to limit disparities by providing preventative medicine and access to resources through its digital tools.
|Quartet Health||Series D||$60||Centene Corporation, F-Prime Capital Partners, GV, Oak HC/FT and Polaris Partners||The latest round will support Quartet’s ongoing expansion, with a particular focus on Medicaid beneficiaries who are in need of behavioral health services.|
Quartet’s integrated platform links providers, payers and services together in its aim to more effectively deliver mental and primary care.
|PathAI||Series B||$60||General Atlantic, General Catalyst and others||The funding will help PathAI pursue new partnerships and build out its existing and in-development service offerings.|
PathAI’s platform employs convolutional neural networks in its analysis of medical images. By doing so, the company’s product can help pathologists diagnose and sub-type cancer and other diseases.
|Noom||Series E||$58||Sequoia Capital, Aglae Ventures, Samsung Ventures, and a number of individual investors including Whats App cofounder Jan Koum, DoorDash cofounder Tony Xu, and Oscar Health cofounder Scooter Braun||The new funding is expected to help the company grow their team and build their customer service capabilities.|
Noom’s platform is focused on creating behavioral health changes related to weight loss, fitness and diet management.
|Talkspace||Series D||$50||Revolution Growth, Northwest Venture Partners, Qumra Capital, Spark Capital and Compound Ventures||The new funding will be put towards expanding Talkspace’s services and accelerating the startup’s commercial business. The company also noted that it plans to expand into international markets and build out new artificial intelligence capabilities.|
Talkspace is a digital platform that connects patients seeking mental health services to providers. Based on a client’s needs, the platform matches them to a therapist. Users can then access clinicians through a telemedicine service and schedule times to talk.
|Cala Health||Series C||$50||Novartis, Baird Capital, LifeSci Venture Partners, TriVentures, JJDC, Lux Capital, Lightstone Ventures, Action Potential Venture Capital, dRx Capital, GV and other unnamed backers.||The funding will kickstart the market launch of Cala Trio, its wearable hand tremor therapy, as well as buff up its therapeutic pipeline.|
Stanford University spinout Cala Health has created a wearable neuromodulation therapy indicated for essential tremor, with other offerings under development focused on neurology, cardiology and psychiatry.
|EverlyWell||Series A||$50||Goodwater Capital, Highland Capital Partners, Next Coast Ventures, NextGen Venture Partners and other unnamed investors.||The company will be using the $50 million to further expand its digital platform and beef up its partnerships with brands like CVS and Humana.|
EverlyWell offers consumers a range of lab tests that can be ordered on the company’s website. Customers receive an breakdown of their results online.
|Solera Health||Series C||$42||HCSC Ventures, BlueCross BlueShield Venture Partners/Sandbox Advantage Fund, Adams Street Partners and SJF Ventures||Solera will be using the funds to “extend the impact of its novel marketplace and payment innovation model.” In particular, the company noted its interest in addressing behavioral health and social determinants of health issues for its customers.|
Solera’s platform hosts a broad selection of digital behavior modification programs that are offered to the members of its health plan and employer customers.
|Elvie||Series B||$42||IPGL, Octopus Ventures and Impact Ventures UK.||The new money will be put towards research and development, as well as growing brand awareness for the two products in the Americas, Europe and Asia.|
The women-led startup has developed two main products in the feminine care space; a pelvic floor trainer and a breast pump.
|Aidoc||Series B||$40||Square Peg Capital||Aidoc is looking to extend its reach to more providers.|
Aidoc’s FDA-cleared and CE-marked solutions support and enhance the impact of radiologist diagnostic power, helping them expedite patient treatment and improve quality of care.
|Bardy Diagnostics||Series B||$35.50||River Cities Capital Funds, HealthQuest Capital, Aperture Venture Partners, Aphelion Capital, Lumira Ventures, Rex Health Ventures, V Health Investors, Health Enterprise Partners and Ascension Ventures||Bardy Diagnostics will be leveraging the funds to expand its sales force and monitoring services, pursue development of augmented intelligence and visualization capabilities, and generally fuel the growth of its platform.|
Bardy Diagnostics’ primary product is the Carnation Ambulatory Monitor (CAM), a P-wave signal-capturing wearable that can be used to remotely monitor patients’ cardiac activity or detect arrhythmia over a seven-day period.
|Biofourmis||Series B||$35||Sequoia India, MassMutual Ventures, EDBI, Jianke, Openspace Ventures, Aviva Ventures and SGInnovate||The company plans to use the new funds to commercialize in the US and Asia and grow its team focused on data science, clinical and regulators and sales operations.|
Using a propriety wearable, a patient-facing app and AI technology, the system is able to create digital biomarkers “reflecting the health status” of a patient. The platform was designed to detect when an adverse health event is about to happen. In part, the system was created to help monitor patients as they take different medications.
|DispatchHealth||N/A||$33||Echo Health Ventures, Alta Partners, Questa Capital and other unnamed backers||The Denver, Colorado-based startup plans to put these new funds towards opening up new locations across the US.|
DispatchHealth’s platform allows patients to request on-demand care to their home. Clinicians will arrive to the patient’s home within two hours of the request and can treat flu, UTI, stomach virus, respiratory conditions and other common health concerns.
|Redox||Series C||$33||Battery Ventures, .406 Ventures, RRE Ventures and Intermountain Ventures||The round will help the company expand its reach and improve its user experience.|
Redox focuses on data interoperability for health apps and other health IT services.
|Zava||Series A||$32||HPE Growth||The company will be using these funds to accelerate its growth.|
Zava is a London-based telemedicine provider active across six European markets.
|DayTwo||Series B||$31||Ofek Ventures, aMoon led the round, Seventure Partners and Johnson & Johnson.||The money will fuel its push into the US market, where it will be seeking partnerships with payers, providers and large employers. In addition, DayTwo will be targeting new products and services focused on metabolic and gastrointestinal conditions.|
DayTwo’s platform asks patients to send a sample of their gut microbiome to the company’s lab, where it is sequenced and characterized alongside blood test results and a user questionnaire. These results are delivered back to the patient as a full report of their gut health, and read by a machine learning algorithm that, through an app, provides the patient with meal scores as well as prediction of how certain food will affect them.
|Vida Health||Series C||$30||GuideWell Mutual Holding Corporation, Teladoc Health, Workday Ventures, unnamed prior backers||Vida plans to scale its sales, marketing and recruiting coaches for platform expansion.|
Vida Health offers multifaceted systems for managing a number of physical and behavioral chronic conditions. The offering includes digital therapeutics, digital communication with live health coaches and, in many cases, connected devices which send biometric data to coaches and apps.
|Carbon Health||Series B||$30||Brookfield Growth Partners, DCVC, Builders VC, Bullpen Capital, Javelin Venture Partners and Two Sigma Ventures||The company said that the funding will be put towards breaching into new markets nationwide. In a statement, the company also noted that it would be using the funds to grow its consumer retail capabilities.|
Carbon is a hybrid of digital and in-person care service. Patients using the service can book an appointment at an urgent or primary care facility in its network. Currently all of the in-person facilities are located in the San Francisco Bay Area.
|LetsGetCheck||Series B||$30||LTP, Optum Ventures, Qiming Venture Partners USA||LetsGetChecked will continue to scale its consumer-facing brand. In addition, the company will also be expanding its North America manufacturing and logistical capabilities, and further developing its core technology.|
The New York City-based company offers consumers a range of lab tests that can be ordered through an online site or partner retailers. Customers receive a kit in the mail, which instructs them how to collect and return a sample to the company, and can view their results and consult through an app.
|CirrusMD||Series B||$26||Drive Capital, the Colorado Impact Fund and other existing investors||The company hasn’t been exceptionally specific about plans for the funding, saying only that it will support their next phase of growth as well as product innovations and existing and new partnerships.|
CirrusMD is part of a smaller group of telemedicine companies that believe text-based chat, not video, is the most efficient and effective vector for telemedicine.
|Phil||Series B||$25||GreatPoint Ventures, Tarsadia Investments, Crosslink Capital and Uncork Capital||The new money will be put towards the company’s growth, with a focus on hiring technical talent and increase its global footprint.|
The platform pitches itself as a way to automate physician, payer pharmacy workflows while helping patients schedule refills.
|Genome Medical||Series B||$23||Echo Health Ventures, LRVHealth, Casdin Capital, Perceptive Advisors, Manatt Venture Fund, Dreamers Fund, Canaan Partners, GE Ventures, Illumina Ventures, Kaiser Permanente Ventures and HealthInvest Equity Partners||The company will be expanding its team of specialists and increasing development of its platform to prepare for further scaling of its services.|
Genome Medical offers providers, payers and employers with a cloud-based “telegenomics” platform. Through it, patients can schedule virtual visits with genetic experts that can deliver counseling, education and other guidance, while providers can arrange for an expert consultation.
|Lifen||N/A||$22.70||Partech, Idinvest Partners, Mayjcc eSanté, Serena, Daphni||Lifen will be accelerating deployment of its solution and doubling its team.|
The commmunications platform aims to enable healthcare organizations and private practitioners exchange medical data securely.
|Cardinal Analytx||Series B||$22||Kleiner Perkins’ John Doerr, GuideWell Mutual Holding Corporation, Blue Shield California and Premera Blue Cross||The money will be invested in new employees and technology that will help the company grow its machine learning and predictive model.|
The Stanford University spinout was founded with the goal of providing predictive population health insights. The company’s tool uses artificial intelligence to predict which patients will have high health spending in the future. It then sets its clients, insurers and providers up with plans to intercept and help patients before their conditions deteriorate.
|Neurotrack||Series C||$21||Khosla Ventures, Dai-ichi Life, SOMPO holdings, Sozo Ventures, Rethink Impact, AME Cloud Partners and Marc Benioff||The new money will be put towards commercializing Neurotrack’s Memory Health Program. The startup is also looking to expand into global markets.|
Neurotrack’s platform was designed with the dual purpose of assessing memory loss and cognitive decline, as well as preventing these conditions from progressing.
|Hydrow||Series A||$20||L Catterton, Rx3 Ventures, Wheelhouse, The Raptor Group, The Yard Ventures||The new funding will help Hydrow grow its business and ship its first devices to early backers.|
Often described as a “Peloton for rowing,” Hydrow’s device offers consumers an in-home rowing workout that is supported by live or on-demand digital courses.
|Trusted Health||Series A||$20||Craft Ventures, Felicis Ventures, Founder Collective, Healthbox and Texas Medical Center||The funding will be used to keep pushing that expansion, with the goal of being in all 50 states and the District of Columbia. The company also wants to expand the list of available opportunities by building out capabilities to support different kinds of jobs, and to generally improve the technology.|
Trusted Health has been building out, and rolling out, a technology platform that helps nurses find jobs and negotiate pay, helps them manage credentialing and paperwork and employs contract nurses as full W2 employees to ensure they get full benefits.
|Welkin||Series B||$17.50||Altos Ventures, Thrive Capital, Red Swan and Asset Management||The company plans to use the new money to expand both its team and product line.|
Welkin was founded in 2013 with a focus on diabetes management but it quickly identified patient engagement workflow tools as a problem area in the space. Now the company focuses on helping its clients tackle issues related to patient engagement workflow.
|mfine||Series B||$17.20||SBI Investment, SBI Ven Captial BEENEXT, Stellaris Venture Partners and Prive Venture Partners|
The new funds will be used to expand its hospital network across the country, build its AI technology and expand the recently launched additional services.
|mfine’s AI healthcare delivery platform currently provides its users access to virtual consultations and connected care programmes from 100 reputed hospitals practice across 20 specialties in India.|
|RxRevu||Series A||$15.90||UCHealth, University of Virginia LVG Venture Fund, Presbyterian Healthcare Services, Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health, JAZZ Venture Partners and existing investors||The new infusion of cash will be put towards growing the company’s platform and technology.|
The company’s platform, called SwiftRX, uses machine learning to help doctors choose which medication to prescribe for their patient, keeping in mind health and financial factors. In addition to a patient’s current diagnosis, the platform will let clinicians see their patient’s medical history, insurance information, and out of pocket costs.
|Modern Fertility||Series A||$15||Forerunner Ventures’s Kirsten Green||Modern Fertility will be funneling the new capital into fertility science research to inform the addition of new offerings into its current product.|
Modern Fertility’s direct-to-consumer business starts when the customer requests a personalized at-home test, or opts to take it at a local lab. Once the results are submitted and reviewed by a clinician, the results are communicated to the customer through a private dashboard housed within a smartphone app or online portal.
|Forefront Telecare||Series A||$15||Tech Council Ventures and Boston Millennia Partners||The startup is planning to use its investment to grow its network of telepsychiatry providers, further develop HIPAA-compliant telehealth platform and push its business into new states.|
Forefront Telecare specializes in providing virtual behavioral telehealth to seniors, and in particular targets Medicare patients in rural hospitals and skilled nursing facilities.
|Kindbody||Series A||$15||RRE Ventures, Perceptive Advisors, Green D Ventures, Trail Mix Ventures and Winklevoss Capital||The company plans to expand into mental health, nutrition and gynecological services in the future. It is also opening a new, larger brick-and-mortar location in New York.|
Kindbody offers women fertility testing, egg freezing, IVF and wellness care. In addition to the brick-and-mortar location in New York, where women can come for fertility treatments, patients can also access virtual care.
|Deep Lens||Series A||$13.70||Northpond Ventures, Rev1 Ventures, Sierra Ventures and Tamarind-Hill Partners||Deep Lens will leverage the new funding to scale its service, sales, and marketing teams, as well as to build upon its artificial intelligence and platform development.|
Deep Lens allows pathologists to study a multitude of digitized bio specimen slides when making a cancer diagnosis.
|Podimetrics||Series B||$13.40||Rock Health, Norwich Ventures and Scientific Health Development||The startup will be expanding its presence within the Department of Veterans Affairs as well as building upon its commercial payer business.|
Podimetrics’ platform consists of a cellular-connected SmartMat for use in the home, and a corresponding clinician-facing dashboard. Users stand on the SmartMat for 20 seconds each day, during which the device collects foot temperature scans and transmits the results to the company’s care team.
|Pillo Health||Series A||$11||Stanley Ventures, Samsung Ventures, BioAdvance, Hikma Ventures, Hackensack Meridien Health System’s Innovation Center Fund and Civilization Ventures||Pillo Health will continue to develop its technology platform, build new voice-based healthcare products for its various partners, support the upcoming US launch of Pria by Black + Decker and hire new employees for its Boston and Genoa, Italy offices.|
Pillo Health’s lead product is the eponymous Pillo, a countertop artificial intelligence device that uses voice to engage users and remind them to take medications. Designed for older patients with chronic diseases or complex care plans, the tool can store, dispense and reorder up to 28 doses of medication on a pre-set schedule. In addition, Pillo can deliver audio- or video-based health content and facilitate video calls between patients and their caregivers, while allowing the latter to monitor adherence data generated from the device.
|Remedy||Series A||$10||Santé Ventures||The funding will scale Remedy’s technology and expand its offerings for self-funded employers.|
Remedy provides both video conferencing with clinicians and house calls through an app. The service is able to treat common aliments like the cold, flu, pink eye, rashes and bronchitis. Patients are also able to get their prescription refills for medications such as birth control, antidepressants and cholesteral medications through the platform.
|Medically Home Group||Series B||$10||Cardinal Health, other unnamed investors||Medically Home will use the funding to scale its at-home care model for more providers and other customers.|
The company pitches its “Virtual Hospital” service as an alternative to lengthy and expensive hospital stays. It deploys monitoring and communication tools in the patient’s home, and supports them with its network of rapid-response clinical and non-clinical services that can deliver medications, equipment and other supplies on demand.
|Onera Health||Series A||$9.30||Jazz Pharmaceuticals, imec.xpand, imec, BOM and other unnamed investors||Although the company did not say specifically how it would be channeling its new funds, the announcement did mention upcoming pilot programs.|
Onera’s in-development diagnostic platform is centered on disposable monitor patches. The product is pitched as an alternative to bulky clinical sensors, as the patches are unobtrusive and can be applied and worn at home.
|NextGen Jane||Series A||$9||Material Impact, Access Industries, Viking Global Investors, Liminal Ventures and unnamed angel investors||The company plans use the new money to continue its scientific data set and get it on track for a 2020 commercialization date.|
The Oakland, California-based startup uses tampons in order to tell women about their reproductive health. The company, which is yet to be launched, is still collecting its clinical data set.
|Future||Series A||$8.50||Kleiner Perkins||Future will be targeting new business partnerships, expanding its go-to-market strategy and building up its trainer operations with the new funding.|
Future pairs consumers with a remote personal fitness coach that will provide weekly training plans that can be adjusted to the individual’s lifestyle. These coaches can check in on users’ smartwatch to ensure that they are following their plans, encourage them through texts, and offer nutrition and lifestyle guidance through the app.
|Sword Health||Series A||$8||Khosla Ventures and unnamed angel investors||Sword Health will pursue further clinical validation, product improvements and new business within North America.|
Sword Health provides tech-enabled physical therapy with a particular focus on musculoskeletal (MSK) disorders.
|Cara Care||Series A||$7||Johnson & Johnson, Asabys Partners, Atlantic Labs||The company will be carrying out additional research and expanding its footbprint through new partnerships.||Cara Care has developed a mobile app aiming to help people affected by digestive health issues manage their symptoms.|| |
|QTC Care||Series A||$7||Tencent and other unnamed investors||The funding will mainly be used for the development of Digital Therapeutics (DTx) and building medical network to service insurance companies.|
QTC Care is a healthcare platform that uses AI to streamline treatment recovery and disease prevention.
|Medbelle||Series A||$6.80||signals Venture Capital, Talis Capital, Mutschler Ventures, IBB Beteiligungsgesellschaft and Cavalry Ventures||The new capital will fuel development of the platform while growing the company’s operating footprint.|
Medbelle describes its offering as a “three-layered digital hospital” that puts patients in charge of their care and helps them navigate care through digital tools.
|Mightier||Series A||$6.60||Foxkiser, Asset Management Ventures and FundRx, Founder Collective, Slow Ventures and Project 11||The company is raising money to expand its team, specifically in the areas of product development, marketing and engineering.|
Mightier offers 25 bioresponsive mobile games, as well as a heart rate monitor (the Mightier Band). The games are designed by popular mobile game developers, but they’re designed to both teach and test emotional regulation skills like deep breathing and visualization. Success at emotional regulation is tied to success in the game.
|Altoida||Series A||$6.30||M Ventures, Grey Sky Venture Partners, VI Partners AGG, Alpana Ventures and FYRFLY Ventures||The new influx of cash will be put towards commercializing the product in the US and European markets.|
Altoida makes a digital platform that employs AI, ML and augmented reality to “collect functional and cognitive biomarkers to help detect Alzheimer’s disease.” The product, which has both an FDA clearance and a CE mark, is meant to detect cognitive decline early on.
|GoCheck||Series B||$6||FCA Venture Partners, Mucker Capital and Sovereign’s Capital.||GoCheck will be focusing on additional EHR integrations and new artificial intelligence capabilities that leverage Apple’s CoreML and ARKit, according to the announcement.|
GoCheck offers FDA-registered software for Apple and Nokia smartphones that allows pediatricians and other healthcare professionals to screen children aged 6 years and younger for amblyopia.
|TransformativeMed||Series A||$5.80||Alliance of Angels||TransformativeMed will be looking to ramp up its sales and marketing, with the ultimate goal of expanding the country-wide reach of its CORES Value Suite product.||Built for use within Cerner hospitals, the company’s CORES Value Suite product platform inserts a handful of clinical workflows for different specialties or conditions into the EHR.|| |
|Oska Wellness||N/A||$5.50||GlobalLink1 Capital, Falls Angel Fund, individual investors||The new money will be put towards its sales, marketing and distribution effots. Additionally, it will also be used to help develop the technology.|
The California-based startup developed a device to help pinpoint and reduce a user’s pain. Using pulsed electromagnetic field therapy, the wearable device emits precise frequencies to the user’s pain point.
|MedCrypt||Series A||$5.30||Section 32, Eniac Ventures and Y Combinator||MedCrypt is looking to expands its sales and engineering teams while continuing to develop its software product.|
MedCrypt sees an opportunity in contracting with the device makers early on to support new or upcoming products. Its software product covers any medical device that has a computer processor, and meets the cybersecurity regulations and recommendations recently stressed by the FDA.
|Vital||Seed funding||$5.20||First Round Capital, Threshold Ventures, Bragiel Brothers, Meridian Street Capital, Refactor Capital and SV Angel||The funding announcement is timed with the public launch of the company, and will support four hospital rollouts and additional sales efforts.|
Vital is offering a patient and clinician-facing AI software for emergency rooms that, while not replacing the EHR (notably the software isn’t designed for billing), aims to replace the EHR’s user experience as much as possible.
|Roundtrip||Series A||$5.10||Motley Fool Ventures, Ben Franklin Technology Partners of Southeastern Pennsylvania, Johns Hopkins University and an unnamed medical device company||The company is looking to build out its software capabilities and more than double its current pool of employees.|
Roundtrip software allows healthcare professionals to order and coordinate patients’ medical transport using a pool of available ride providers, whether they be Lyft drivers, facility-owned vehicles, volunteers or otherwise. The platform is available online and as a mobile app, and includes interfaces for providers and patients alike.
|Savonix||Series A||$5.10||Fusion Fund, Wavemaker Partners, DEFTA Partners, Rethink Impact and DigiTx Partners||The funding will be used to build out the technology, though the company isn’t sharing too many details on specific features yet.|
Savonix’s flagship app, Savonix Mobile, is a 30-minute brain training and testing app based on existing clinical guidelines and procedures.
|Astarte Medical||Series A||$5||Viking Global Investors, Lunsford Capital, OCA Ventures, Keiretsu Forum MidAtlantic, Keiretsu Capital Fund, Ben Franklin Technology Partners, Wing VC and Next Act Fund||The investment will be used to complete the development of NICUtrition.|
Astarte is building a suite of tools for the neonatal intensive care unit (NICU) called NICUtrition. The software suite will be built on a proprietary database of feeding protocols, microbial profiles and clinical information which will power predictive analytics that can advise care teams on protocols and treatment plans.
5Lion Ventures, Hospital for Special Surgery and ID Fund
|The company plans to use the new money to grow its geographical reach, as well as user adoption.|
The New York-based startup helps patients find physical therapists in their area using a mobile app. After a user searches for clinics in their area, they are able to request an appointment through the app.
|ExplORer Surgical||Series A follow on||$5||Aphelion Capital, prior investors and new unnamed backers||The company will be looking to build up its user base and introduce new features to the platform.|
ExplORer Surgical’s provider-facing platform looks to help surgical teams better coordinate tasks or instrumentation. The “digital playbook” provides info on which instruments or supplies to use in the moment, while recording which tools are used for the organization to review.
|Jio Health||Series A||$5||Monk Hill’s Ventures||The new funds will be used by Jio Health to scale its operations and capabilities across Vietnam.|
The startup currently operates an online healthcare app (available on iOS and Android platforms) and a physical facility in Saigon. It provides on-demand access to healthcare services such as primary care, chronic disease management, pediatrics and ancillary care services.
|Meru Health||Seed funding||$4.20||Freestyle Capital, Bonit Capital, Y Combinator, Lifeline Ventures and IT-Farm||The startup said the new money will be put towards additional clinical validation and preparations for a larger rollout to health systems and employers.|
Meru offers a digital mental health tool that is supported by licensed therapists. The program lasts 12 weeks, and each week has a different theme that builds on the previous one.
|DynamiCare Health||Seed funding||$4.10||Hyperplane Venture Capital, former US Representative Patrick J. Kennedy and other unnamed investors||DynamiCare plans to use its new millions to launch a consumer version of its app within the coming months, as well as to upgrade its telehealth coaching services.|
DynamiCare Health has built a platform supports users’ substance use disorder recovery with a number of smartphone-based features.
|Infermedica||N/A||$3.65||Karma Ventures, Dreamit Ventures, Inovo Venture Partners and Müller Medien||The company will be launching its service in the US.|
Patients using Infermedica’s platform are able to enter their chief complaint into a symptom checker. Using artificial intelligence, the platform will then ask the patient another set of questions.
|NuvoAir||N/A||$3||Inustrifonden and Investment AB Spiltan||NuvoAir plans to use the new money to grow its team, as well as fuel its development pipeline and clinical trials. It is also looking to expand globally.|
The company made a name for itself with a smartphone spirometer able to conduct lung function assessments in a home environment.
|Giblib||Seed funding||$2.50||Mayo Clinic, the Venture Reality Fund, Wavemaker 360, USC Marshall Venture Fund and Michelson 20MM.||The seed round will help Giblib to build out its offerings technically as well as form additional partnerships and expand the amount of content available in its streaming library.|
Giblib works with hospitals to offer a streaming service filled with 4K and 360 degree VR videos of both medical lectures and surgeries.
|Closed Loop Medicine||Pre-Series A||$2.30||Longwall Venture Partners, IQ Capital and Martlet||The new funding will underpin the development of a “drug + digital approach” aiming to treat various health conditions, initially looking at hypertension and sleep disturbance.|
The Cambridge startup, which describes itself as a “new breed of therapeutics company,” says its approach is based on using data and insights about how patients are responding to treatments to tailor drug and non-drug therapy.
|Feebris||Seed funding||$1.40||Innovate UK and 24 Haymarket||The investment will support Feebris’ AI-enabled platform to continue bridging the gap between the community and providers across a range of respiratory conditions including pneumonia, COPD and asthma.|
The British startup is focused on using artificial intelligence to identify physiological markers that put a patient at-risk of deteriorating.
|Blueprint||N/A||$1.30||Lightbank and Hyde Park Angels||Blueprint will be using its new funding to beef up its engineering and sales teams while expanding clinician outreach.|
Blueprint’s app-based platform distributes standardized clinical assessments to patients and automatically logging behavioral factors such as sleep or exercise with the smartphone’s sensors.
|iWEECARE||Pre-Series A||$1||Verge HealthTech Fund, Translink Capital and Darwin Venture||The company will support its flagship product, Temp Pal.|
The company’s Temp Pal product is a comprehensive and convenient wireless body temperature tracking solution that offers real-time monitoring combined smart alerts, seeking to disrupt a market forecasted to reach $1.5B by 2025 currently dominated by digital pen and in-ear thermometers.
|Feedtrail||Seed funding||$1||Dioko Ventures and an unnamed non-profit health system||Feedtrail plans to use the new money to hire sales and marketing staff. It will also be put towards scaling the platform.|
Founded in 2015, the North Carolina-based startup specializes in phone-based patient satisfaction surveys. The platform then is able to analyze these survey results and give providers feedback based on where they are falling short. It also gives providers possible strategies and methods that could help solve any logistical issues.
|Nori Health||Pre-seed funding||$0.68|| |
Nori has developed and tested a chatbot for people with inflammatory bowel disease.
|RelayOne||Seed funding||$0.50||Cofounders Capital||RelayOne use the new funding to launch its software.|
RelayOne has created a secure software platform that disseminates that scheduling information to all the relevant stakeholders in real time. It works with EHRs and is designed to be HIPAA-compliant.
|Medly||Series A||undisclosed||Greycroft||The startup said it plans to use the infusion of funds to help it expand its services nationally.|
The New York City-based startup provides same-day delivery of a patient’s prescription medication. A patient can have their provider send their prescriptions to the Medly platform.
|Theranica||Series B add-on||Undisclosed||Omron Ventures||Theranica said in March that its current round will support mass production of its Nerivio Migra device.|
Theranica is a biomedical technology company focused on developing advanced electroceuticals for migraine and other prevalent diseases.
|Medigo||Seed funding||Undisclosed||Venturra Discovery||Medigo is running a pilot of its product.|
The startup focuses on connecting healthcare facilities with the mission to “build a better, more connected Indonesian digital healthcare ecosystem.”
Source : MobiHealthNews